3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
32
Multiple Myeloma
21
Hodgkin Disease
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma
12
Leukemia, Myeloid, Acute
11
Leukemia, Lymphocytic, Chronic, B-Cell
9
Myelodysplastic Syndromes
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Neoplasms, Plasma Cell
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Hairy Cell
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Myeloproliferative Disorders
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Bortezomib
4
fludarabine
3
Lenalidomide
3
dacetuzumab
2
Tacrolimus
2
Dexamethasone
2
Alemtuzumab
2
plerixafor
1
ofatumumab
1
isatuximab
1
fludarabine phosphate
1
ficlatuzumab
1
epratuzumab
1
Whole-Body Irradiation
1
Vorinostat
1
Stem Cell Transplantation
1
Rifaximin
1
Mycophenolic Acid
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Erlotinib Hydrochloride
1
Cyclophosphamide
1
Clonal Hematopoiesis
1
Chromatin Immunoprecipitation Sequencing
1
Calcium Dobesilate
1
CLR1404
1
Busulfan
1
Blood Cell Count
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraproteinemias
×
plerixafor
×
Lymphoid
×
Clear all
NCT01186224
2025-03-17
PHANTASTIC
University of Liverpool
Phase NA
Completed
60 enrolled